Ayuda destinada a las Startups innovadoras de base tecnológica y PYMES de alta intensidad innovadora (RIS3) – 11/01/2021

Grants aligned with the Regional Strategy for Research and Innovation for Smart Specialization (RIS3). They target technology-based startups and high-intensity innovative SMEs to catalyze regional economic transformation through cutting-edge R&D projects.

Project title: Implementation of a high-resolution universal test to quantify residual disease in peripheral blood using circulating cell-free DNA (cfDNA) and circulating tumor cells (CTCs) in cancer patients (DUALMRDTest-CAM2020).

Objective: To develop next-generation sequencing (NGS) technologies for detecting and quantifying Minimal Residual Disease (MRD) with high precision, enabling personalised cancer monitoring. Its primary objective is to optimise the early detection of relapses and treatment selection, improving clinical decision-making.

Project code: STARTUP-2020\L2-566.

Acronym: RIS3 2020 / DualMRDtest

Reference: EREG 49/235920.9/20

Funding entity: Comunidad de Madrid

Duration: N/A

Money granted: 125.000€